Adoption of prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (ES-SCLC): a population based outcome study.
Yu Yang SoonHuili ZhengShaun Zhirui HoWee Yao KohCheng Nang LeongJeremy Chee Seong TeyBalamurugan VellayappanSwee Peng YapIvan Weng Keong ThamKam Weng FongPublished in: Radiation oncology (London, England) (2018)
There was an increase in the adoption of PCI for ES-SCLC since 2007. PCI was associated with improved survival in patients who did not have mandatory MRI brain imaging prior to PCI and had stable disease or better after first line chemotherapy, suggesting that the results of the European RCT are reproducible in the real-world practice.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- small cell lung cancer
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- atrial fibrillation
- coronary artery bypass grafting
- electronic health record
- healthcare
- magnetic resonance imaging
- white matter
- contrast enhanced
- computed tomography
- magnetic resonance
- heart failure
- left ventricular
- squamous cell carcinoma
- locally advanced
- radiation therapy
- photodynamic therapy
- cerebral ischemia
- free survival
- brain injury
- mass spectrometry